TNF and cancer: The CESAME study group published the results of a prospective assessment examining the risk of new or recurrent cancer in IBD patients with a history of cancer, whether or not they were receiving immunosuppressants such as thiopurines, methotrexate (MTX), or TNF inhibitors [54].